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Abstract 1 
Although oxfendazole (OFZ) is a well know broad-spectrum benzimidazole anthelmintic, the 2 
assessment of its potential trematodicidal activity remains unexplored. OFZ administration at single 3 
high doses has been recommended to control Taenia solium cysticercus in pigs. The current study 4 
investigated the flukicidal activity obtained after a single high (30 mg/kg) oral dose of OFZ in pigs 5 
harbouring a natural Fasciola hepatica infection. Sixteen (16) local ecotype pigs were randomly 6 
allocated into two (2) experimental groups of 8 animals each named as follow: Untreated control and 7 
OFZ treated, in which animals received OFZ (Synanthic®, Merial Ltd., 9.06% suspension) orally at 30 8 
mg/kg. At seven (7) days post-treatment, all the animals were sacrificed and direct adult liver fluke 9 
counts were performed following the WAAVP guidelines. None of the animals involved in this 10 
experiment showed any adverse event during the study. OFZ treatment as a single 30 mg/kg oral dose 11 
showed a 100% efficacy against F. hepatica. In conclusion, the trial described here demonstrated an 12 
excellent OFZ activity against F. hepatica in naturally infected pigs, after its administration at a single 13 
oral dose of 30 mg/kg.  14 
   15 
Key words: Oxfendazole, Fasciola hepatica, Efficacy, Pigs.  16 
17 
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1. Introduction 1 
Oxfendazole (OFZ) is a methyl-carbamate benzimidazole compound, indicated for the control of 2 
gastrointestinal and lung nematodes and cestodes. OFZ was first marketed to be used in cattle, sheep 3 
and horses. Additionally, OFZ has demonstrated activity against Taenia solium cysticercus in pigs after 4 
its single oral administration at 30 mg/kg (Gonzales et al., 1996). OFZ treatment of T. solium-infected 5 
pigs has been proposed as a tool to interrupt the transmission cycle of this parasite, protecting people 6 
from neurocysticercosis, the most common parasitic infection of the human nervous system and the 7 
most frequent preventable cause of epilepsy in endemic areas of Latin America, Africa and Asia 8 
(Gonzales et al., 1996). The WHO estimated that globally, the parasite causes 50 million human cases 9 
of taeniasis (infection with adult tapeworms) and cysticercosis, and 50,000 human deaths per year in 10 
Africa, Asia and Latin America (WHO, 2012). In a recent study, OFZ orally administered to naturally 11 
parasitized piglets at a single dose of 30 mg/kg was safe and highly efficacious (100%) against adult 12 
stages of Ascaris suum, Oesophagostomum spp., Trichuris suis and Metastrongylus spp. (Alvarez et al., 13 
2013).  14 
 15 
Fascioliasis, caused by the trematode liver fluke Fasciola hepatica, is the cause of considerable loss in 16 
sheep and cattle production systems all over the world (Roberson and Courtney, 1995). Human 17 
fascioliasis occurs as an accidental zoonotic disease in Africa, Western Europe and Latin America 18 
(Mas-Coma et al., 2005). Considered a secondary zoonotic disease until the mid-1990s, human 19 
fascioliasis is at present emerging or re-emerging in many countries, including increases of prevalence 20 
and intensity and geographical expansion (Mas-Coma, 2005). Human fascioliasis is considered by the 21 
WHO as an important human parasitic diseases, with estimates of 2.4 million (Rim et al., 1994) up to 22 
17 million infected people (Hopkins, 1992). These figures could be even larger depending upon the 23 
unknown situations in many countries, mainly in Asia and Africa (Mas-Coma, 2005).   Sheep and cattle 24 
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are considered the main reservoir host species of F. hepatica (Hillyer et al., 1996; Mas-Coma et al., 1 
1997; 1999) but other species may provide a reservoir of infection. Pigs may play an important role in 2 
fascioliasis transmission. For instance, fascioliasis has been reported in pigs from different 3 
geographical areas, including Africa (El-Rafaie et al., 1984), Asia (Boes et al., 2000) and South 4 
America (Mas-Coma et al., 1997). Valero and Mas-Coma (2000) found that there were no differences 5 
in the infectivity of the metacercariae between sheep, cattle and pig isolates from the Bolivian 6 
Altiplano, and in this geographical area F. hepatica adult development in the pig is similar to that 7 
observed in sheep and cattle. The available epidemiological data suggest that pigs may play an 8 
important role in fascioliasis transmission in hyperendemic areas and must, consequently, be taken into 9 
account when applying control measures (Valero et al., 2001).  10 
 11 
The main strategy for the effective control of fascioliasis is based on chemotherapy. However, there are 12 
not anthelmintic compounds approved for the control of F. hepatica in pigs. The halogenated 13 
benzimidazole triclabendazole has demonstrated to be active against liver flukes in pigs artificially 14 
infected with F. hepatica metacercariae (Olaechea et al., 1989). However, at present triclabendazole is 15 
not indicated to be used in pigs. In spite of its broad-spectrum activity against gastrointestinal 16 
nematodes, OFZ is not indicated against F. hepatica (McKellar and Scott, 1990). However, some in 17 
vitro ovicidal activity against F. hepatica eggs was previously reported (Alvarez et al., 2009), and it is 18 
likely that a high dose of this benzimidazole compound may have flukicidal activity in domestic 19 
animals, including pigs. In fact, in a recent study (Gomez-Puerta et al., 2012) performed in sheep, 20 
flukicidal activity measured by the faecal egg count reduction test (FECRT), was reported after a single 21 
OFZ dose. The potential of OFZ use in pigs at 30 mg/kg as a single oral dose against F. hepatica 22 
should be investigated to search for a broader therapeutic indication for this anthelmintic compound, 23 
when used as a single oral dose for the treatment of porcine cysticercosis. The goal of the current work 24 
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was to assess the flukicidal activity of a 9.06% OFZ suspension administered as a single oral dose (30 1 
mg/kg) in pigs naturally infected with F. hepatica. 2 
 3 
 4 
 5 
2. Material and methods  6 
2.1. Animals  7 
Local ecotype commercial pigs naturally parasitized with F. hepatica were involved in the current trial. 8 
Pigs were fed ad libitum with a commercial balanced food and had free access to water. A 10 days 9 
acclimatization period was allowed for the experimental animals. Animals were housed in two different 10 
pens with concrete floors, protected from rain and prevailing winds, but without temperature control. 11 
The animal phase of the current experiment was performed in the Faculty of Veterinary Science, 12 
Universidad Nacional de Cajamarca, Cajamarca, Perú.  13 
 14 
2.2. Experimental design  15 
Sixteen pigs (28.0 ± 4.9 kg, 6-7 months old), naturally parasitized with F. hepatica were randomly 16 
distributed into two groups (n= 8 each): Untreated control and OFZ treated group. Parasite infection 17 
was confirmed by faecal egg counts (FEC) performed according Mooney et al., (2009). Briefly, 3 g of 18 
faeces was added with water, and the contents was mixed thoroughly and poured through a tea strainer 19 
to remove large debris. The filtrate was then allowed sediment for 10 min after which the supernatant 20 
was siphoned off taking care not to disturb the sediment. The sediment was stained with two drops of 21 
methylene blue and the entire sediment were assessed for liver fluke eggs using an optical microscope 22 
(x40 magnification). The number of F. hepatica eggs observed was counted and the eggs per gram 23 
(epg) of faecal material was calculated. In the OFZ treated group, treatment was performed by oral 24 
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administration of OFZ (Synanthic®, OFZ 9.06%, Merial, France) at the dose of 30 mg/kg.  Seven days 1 
after treatment, animals were sacrificed and direct trematode counts of animals from the untreated 2 
control and OFZ treated groups were performed following the WAAVP guidelines (Hennessy et al., 3 
2006). The total number of F. hepatica was recovered and counted according to Hennessy et al., 4 
(2006). Briefly, at necropsy, the gall bladder and liver of pigs was examined for living and dead F. 5 
hepatica. After incising the gall bladder and bile ducts, the liver was cut along the large and small bile 6 
ducts and hepatic veins and searched for flukes. Then the liver was cut into thin slices (0.5–1.0 cm in 7 
width), soaked in warm (37 °C) saline in appropriate trays. The recovered liver flukes were transferred 8 
to Petri dishes, filled with saline, and examined for vitality and appearance. The evaluation of adult 9 
liver fluke burdens was done “blindly”. The OFZ efficacy was determined by the comparison of worm 10 
burdens in treated versus untreated control animals. The following equation expresses the percentage of 11 
efficacy (%E) against F. hepatica for the OFZ treated group (T) when compared with the untreated 12 
control (C): %E= [(mean of S in C – mean of S in T) / mean of S in C] x 100. The geometric mean was 13 
used as it most accurately represents the distribution of parasite populations within each group 14 
(Hennessy et al., 2006). The criterion for efficacy was statistically significant differences in fluke 15 
burdens between treated and untreated control groups and efficacy ≥ 90%. Nematode counts were 16 
compared by non parametric unpaired test (Mann-Whitney) of log-transformed data. A value of P<0.05 17 
was considered statistically significant. The statistical analysis was performed using the Instat 3.0 18 
Software (Graph Pad Software, CA, USA). Animal procedures and management protocols were carried 19 
out in accordance with the Animal Welfare Policy (Act 087/02) of the Faculty of Veterinary Science, 20 
Universidad Nacional de Cajamarca, Cajamarca, Peru.  21 
 22 
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3. Results 1 
None of the animals involved in the current trial showed any adverse event during the study. This was 2 
in agreement with a previously reported trial where the 9.06% OFZ formulation was orally 3 
administered to pigs at 30, 90 and 150 mg/kg daily for three consecutive days, with a partial reduction 4 
on feed intake during two to three days post-treatment in the groups treated with the highest OFZ doses 5 
as the main clinical change on the health status of the treated pigs (Alvarez et al., 2012a). OFZ has a 6 
large therapeutic index in the mammalian host, which explains the absence of appreciable toxic effect 7 
in pigs treated with a single dose of 30 mg/kg. The individual FEC and adult liver fluke counts 8 
obtained for the untreated control and OFZ treated group, and the efficacy observed after the OFZ 9 
treatment are shown in Table 1.  10 
 11 
A large variation in worm burdens was observed among experimental animals. In the control group, 4 12 
to 140 adult flukes were recovered from the biliary duct. Furthermore, the FEC showed a large 13 
variability ranging from 1 to 820 eggs/3 g of faeces. However, no statistical difference (P> 0.05) was 14 
observed in FEC between the treated and untreated animals. Animal #4 in the untreated control group 15 
had an unusually high egg count in 3 g of faecal material (820). The variation in liver fluke burdens 16 
observed among experimental animals could be explained by the fact that them were obtained from 17 
different farms, likely with different environmental contamination levels. Consequently, experimental 18 
pigs could had been exposed to different metacercariae infection pressure. Even though the large 19 
parasite infection variability observed in the current trial, a high efficacy (100%) against F. hepatica in 20 
pigs was observed after the OFZ treatment at 30 mg/kg. 21 
 22 
 23 
 24 
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4. Discussion 1 
Anthelmintic drugs are the main available tool to control parasitic infections, including liver flukes. 2 
There are many compounds derived from different chemical families approved as flukicidal drugs for 3 
use in sheep and cattle. However, available information on successful anthelmintic treatments against 4 
liver flukes in pigs is scarce. Earlier work by Olaechea et al., (1989) demonstrated the activity  of 5 
triclabendazole at doses of 10 to 40 mg/kg, given to pigs at day 21 after the experimental infection with 6 
100 F. hepatica metacercariae. However, no effective anthelmintic treatment is currently available for 7 
removing liver flukes from pigs. The use of benzimidazole compounds as broad-spectrum 8 
anthelmintics in all age groups of pigs is a common practice in different regions of the world 9 
(Theodoropoulos et al., 2001; Beloeil et al., 2003). The oral OFZ single-dose therapy is a practical and 10 
easy technique for pig deworming in extensive production systems, such as those observed in some 11 
areas in developing countries. This OFZ treatment is useful for cysticercosis (Gonzales et al., 1997) and 12 
adult nematode control (Alvarez et al., 2013). Additionally, the single OFZ oral administration at 30 13 
mg/kg dose reached an outstanding flukicidal activity in the experimental work described here.  14 
 15 
The benzimidazole anthelmintics active against F. hepatica include the methylcarbamate derivative 16 
albendazole, and the halogenated thiol benzimidazole derivative, triclabendazole. The pro-17 
benzimidazole netobimin is also active against F. hepatica, but since it is metabolically converted to 18 
albendazole in the rumen of treated sheep/cattle (Lanusse and Prichard, 1993), its activity must be 19 
linked to albendazole. While albendazole activity is restricted to flukes older than 12 weeks (McKellar 20 
and Scott, 1990), triclabendazole has been shown to have an excellent efficacy against both the mature 21 
and immature adult stages of F. hepatica (Boray et al. 1983), which explain why this compound has 22 
been the drug of choice for treating liver fluke infections in livestock for over 20 years. In previous 23 
studies in sheep, OFZ at the oral dose of 5 and 15 mg/kg reached flukicidal efficacies of 14% and 20%, 24 
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respectively (Furmaga et al., 1982). This low efficacy could be related to a “pharmacodynamic 1 
limitation” due to a lack drug-receptor affinity. However, a recent report demonstrated that none of the 2 
sheep treated with OFZ (single oral dose, 30 mg/kg) showed F. hepatica eggs in faeces after 10 days of 3 
treatment (Gomez-Puerta et al., 2012). The same oral dose was highly effective against adult flukes in 4 
pigs, as show in the current reported trial. Thus, the limited efficacy observed in earlier efficacy trials 5 
appears to be due to a pharmacokinetic-based limited parasite exposure and/or a lower OFZ receptor 6 
affinity. As it has been described in nematodes (Alvarez et al., 2012b), the higher the OFZ 7 
accumulation within the liver fluke, the greater the resultant clinical efficacy.  8 
 9 
The increase on the albendazole dose was associated with enhancement in the plasma exposure of its 10 
metabolites in sheep (Moreno et al., 2004; Alvarez et al., 2012b). In the same way, a 235% increment 11 
in OFZ plasma concentration in pigs was observed at 5 days post-treatment after 90 mg/kg (5.7 ± 2.6 12 
µg/mL) compared with 30 mg/kg dose (1.7 ± 1.1 µg/mL; Alvarez et al, 2012a). It is clear that at least 13 
under a certain dose range, the higher the OFZ dose given to pigs the greater the amount of drug 14 
absorbed at the GI level. After OFZ treatment in pigs (30 mg/kg), an OFZ peak plasma concentration 15 
of 5.40 ± 0.65 µg/mL and an AUC of 209.9 ± 33.9 µg.h/mL were reported (Moreno et al., 2012). This 16 
OFZ plasma exposure is much larger than that observed in pigs, after the administration of the parent 17 
thioether fenbendazole, which is rapidly and extensively converted in vivo into its active sulphoxide 18 
metabolite OFZ (Lanusse and Prichard, 1993). After a fenbendazole oral dose (5 mg/kg) in pigs the 19 
observed OFZ peak plasma concentration (Cmax) and area under the plasma concentration vs time 20 
curve (AUC) values were 0.66 ± 0.22 µg/mL and 15.6 ± 5.24 µg.h/mL, respectively (Petersen and 21 
Friis, 2000). The high OFZ plasma exposure observed after a single OFZ dose of 30 mg/kg in pigs 22 
assures the trematode parasite being exposed to toxic drug concentrations for extended periods of time, 23 
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which may help to explain the high efficacy against F. hepatica in naturally infected pigs, described in 1 
the current work.  2 
 3 
5. Conclusion 4 
OFZ administered as a single oral dose of 30 mg/kg to naturally parasitized pigs, was safe and highly 5 
efficacious (100%) against adult stages of F. hepatica. The findings reported here may have a great 6 
impact for liver fluke control in swine, particularly in those geographical areas where pigs play an 7 
important role as reservoirs for human fascioliasis.  8 
 9 
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Table 1: Individual pre-treatment (trial day -1) faecal egg counts (FEC), post-treatment fluke counts (trial day 7) and 1 
efficacy against Fasciola hepatica, obtained in naturally infected pigs from the untreated control group and the orally 2 
treated (30 mg/kg) with oxfendazole (OFZ).   3 
 4 
 5 
 6 
FEC is 7 
expressed as 8 
egg in 3 g of 9 
faeces, 10 
estimated at 11 
trial day -1 12 
(pre-13 
treatment). No 14 
statistical 15 
difference (P> 16 
0.05, Mann-17 
Withney test) 18 
in the FEC 19 
was observed 20 
between the Control and the OFZ treated group.  *Statistically different (P< 0.05, Mann-Withney test) adult fluke counts 21 
between the Control and the OFZ treated group. 22 
 23 
 24 
 25 
 26 
27 
FEC Adult F. hepatica counts 
Animal # 
Control OFZ-treated Control OFZ-treated 
1 32 7 4 0 
2 2 1 4 0 
3 4 7 23 0 
4 820 13 140 0 
5 34 6 9 0 
6 14 48 5 0 
7 27 33 8 0 
8 1 85 8 0 
Geometric mean 15.1 12.3 8.3 0* 
Efficacy (%) - - - 100 
Page 16 of 18
Ac
ce
pte
d M
an
us
cri
pt
 16
HIGHLITGHTS 1 
 2 
Control measures in F. hepatica-endemic areas should include treatments in swine. 3 
There are not available anthelmintic treatments to control F. hepatica in pigs. 4 
The flukicidal activity of oxfendazole in pigs was assessed.  5 
Oxfendazole (oral, 30 mg/kg) was 100% efficacious against F. hepatica in pigs. 6 
 7 
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Oxfendazole flukicidal activity in pigs  
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The current study investigated the flukicidal activity obtained after a single (30 mg/kg) oral dose of 
oxfendazole in pigs harbouring a natural Fasciola hepatica infection.  
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